Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute osteomyelitis of the ilium.

Irish journal of medical science·2016
Same author

Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek--an oral multi-agent natural supplement.

The Canadian journal of urology·2008
Same author

Responsiveness of symptom scales for interstitial cystitis.

Urology·2006
Same author

A pilot open label study of Cystoprotek in interstitial cystitis.

International journal of immunopathology and pharmacology·2005
Same author

A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis.

The Journal of urology·2003
Same author

Intravesical sodium hyaluronate inhibits the rat urinary mast cell mediator increase triggered by acute immobilization stress.

The Journal of urology·2001

Related Experiment Video

Updated: Dec 26, 2025

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

9.6K

Interstitial cystitis

G R Sant1

  • 1Department of Urology, New England Medical Center Hospitals, Boston, MA 02111, USA. grannum.sant@es.nemc.org

Current Opinion in Obstetrics & Gynecology
|November 14, 1997
PubMed
Summary
This summary is machine-generated.

Interstitial cystitis is a complex bladder condition with varied symptoms. Pentosan polysulfate sodium offers a new oral treatment option, but more research is needed on its gynecologic and pain-related aspects.

More Related Videos

Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.8K
Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

18.2K

Related Experiment Videos

Last Updated: Dec 26, 2025

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation
09:49

Assessment of Perigenital Sensitivity and Prostatic Mast Cell Activation in a Mouse Model of Neonatal Maternal Separation

Published on: August 13, 2015

9.6K
Establishment and Characterization of UTI and CAUTI in a Mouse Model
08:40

Establishment and Characterization of UTI and CAUTI in a Mouse Model

Published on: June 23, 2015

20.8K
Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice
11:46

Urinary Bladder Distention Evoked Visceromotor Responses as a Model for Bladder Pain in Mice

Published on: April 27, 2014

18.2K

Area of Science:

  • Urology
  • Immunology
  • Pharmacology

Background:

  • Interstitial cystitis (IC) is a chronic urologic pain disorder with diverse pelvic symptoms.
  • Current research suggests a non-bacterial origin, potentially involving autoimmune factors, bladder lining defects, sensory neuropeptide activation, and mast cell degranulation.

Purpose of the Study:

  • To review the current understanding of interstitial cystitis.
  • To highlight the potential of pentosan polysulfate sodium as an oral therapeutic agent.
  • To identify areas requiring further investigation, particularly gynecologic and pain management aspects.

Main Methods:

  • Literature review of existing research on interstitial cystitis.
  • Analysis of the proposed mechanisms of action for pentosan polysulfate sodium.
  • Identification of knowledge gaps in IC research.

Main Results:

  • Interstitial cystitis presents with multifaceted pelvic pain and urologic, gynecologic, and gastrointestinal symptoms.
  • Evidence suggests potential autoimmune involvement and local bladder wall abnormalities.
  • Pentosan polysulfate sodium has been approved as an oral treatment for IC.

Conclusions:

  • Interstitial cystitis is a complex condition with multifactorial origins.
  • Pentosan polysulfate sodium represents a new therapeutic avenue for managing IC symptoms.
  • Further research is essential to fully understand and manage the gynecologic and pain components of interstitial cystitis.